Population pharmacokinetics of levocetirizine in very young children: The pediatricians' perspective

Pediatric Allergy and Immunology

Volumn 16, Issue 2, 2005, Pages 97-103

  Simons, F Estelle R ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b NONE   (Canada)

Author keywords

Allergy; Cetirizine; H1 antihistamine; Levocetirizine; Population pharmacokinetics; Young child

Indexed keywords

ALLERGEN; CETIRIZINE; CORTICOSTEROID; HISTAMINE H1 RECEPTOR ANTAGONIST; HYDROXYZINE; LEVOCETIRIZINE; MACROLIDE; PENICILLIN DERIVATIVE; PLACEBO;

AGE; ALLERGIC DISEASE; BLOOD SAMPLING; BODY WEIGHT; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISTRIBUTION VOLUME; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG EXCRETION; DRUG METABOLISM; DRUG MONITORING; DRUG SAFETY; ENANTIOMER; EOSINOPHILIA; FEMALE; GASTROENTERITIS; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NONLINEAR SYSTEM; PATIENT COMPLIANCE; PEDIATRICIAN; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REVIEW; SENSITIZATION; STEADY STATE;

ADMINISTRATION, ORAL; CETIRIZINE; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HUMANS; INFANT; MODELS, STATISTICAL; PEDIATRICS; PHYSICIANS; PIPERAZINES;

EID: 17044390173     PISSN: 09056157     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3038.2005.00240.x     Document Type: Review

References (35)

1. 1-Antihistamines in Allergic Disease, 2nd edn. New York: Marcel Dekker, Inc., 2002: 437-64.
2. STEINBROOK R. Testing medications in children. N Engl J Med 2002: 347: 1462-70.
3. KEARNS GL. Impact of developmental pharmacology on pediatric study design: overcoming the challenges. J Allergy Clin Immunol 2000: 106(Suppl. 3): S128-38.
4. KEARNS GL, ABDEL-RAHMAN SM, ALANDER SW, BLOWEY DL, LEEDER JS, KAUFFMAN RE. Developmental pharmacology - drug disposition, action, and therapy in infants and children. N Engl J Med 2003: 349: 1157-67.
5. SPICAK V, DAB I, HULHOVEN R, et al. Pharmacokinetics and pharmacodynamics of cetirizine in infants and toddlers. Clin Pharmacol Ther 1997: 61: 325-30.
6. 1-receptor antagonist cetirizine in very young children. Clin Pharmacol Ther 1993: 53: 431-5.
7. PARIENTE-KHAYAT A, REY E, DUBOIS MC, et al. Pharmacokinetics of cetirizine in 2- to 6-year-old children. Int J Clin Pharmacol Ther 1995: 33: 340-4.
8. CRANSWICK NE, FUCHS M, TURZIKOVA J. Efficacy, safety and pharmacokinetics of levocetirizine in allergic children age 1-2 years. Clin Pharmacol 2004: 75: P46.
9. SALMUN LM, HERRON JM, BANfiELD C, PADHI D, LORBER R, AFFRIME MB. The pharmacokinetics, electrocardiographic effects, and tolerability of loratadine syrup in children aged 2 to 5 years. Clin Ther 2000: 22: 613-21.
10. SCHMIDT-REDEMANN B, BRENNEISEN P, SCHMIDT-REDEMANN W, GONDA S. The determination of pharmacokinetic parameters of ketotifen in steady state in young children. Int J Clin Pharmacol Ther Toxicol 1986: 24: 496-8.
11. SIMONS FER, SIMONS KJ, BECKER AB, HAYDEY RP. Pharmacokinetics and antipruritic effects of hydroxyzine in children with atopic dermatitis. J Pediatr 1984: 104: 123-7.
12. SIMONS KJ, WATSON WTA, MARTIN TJ, CHEN XY, SIMONS FER. Diphenhydramine: pharmacokinetics and pharmacodynamics in elderly adults, young adults, and children. J Clin Pharmacol 1990: 30: 665-71.
13. SIMONS FER, LUCIUK GH, SIMONS KJ. Pharmacokinetics and efficacy of chlorpheniramine in children. J Allergy Clin Immunol 1982: 69: 376-81.
14. SIMONS FER, ROBERTS JR, GU X, KAPUR S, SIMONS KJ. The clinical pharmacology of brompheniramine in children. J Allergy Clin Immunol 1999: 103: 223-6.
15. WATSON WTA, SIMONS KJ, CHEN XY, SIMONS FER. Cetirizine: a pharmacokinetic and pharmacodynamic evaluation in children with seasonal allergic rhinitis. J Allergy Clin Immunol 1989: 84: 457-64.
16. LIN CC, RADWANSKI E, AFFRIME MB, CAYEN MN. Pharmacokinetics of loratadine in pediatric subjects. Am J Ther 1995: 2: 504-8.
17. SIMONS FER, BERGMAN JN, WATSON WTA, SIMONS KJ. The clinical pharmacology of fexofenadine in children. J Allergy Clin Immunol 1996: 98: 1062-4.
18. SIMONS FER, WATSON WTA, SIMONS KJ. Pharmacokinetics and pharmacodynamics of ebastine in children. J Pediatr 1993: 122: 641-6.
19. SIMONS ER, GORITZ SS., SIMONS KJ. Clinical pharmacology of levocetirizine, the active enantiomer of cetirizine, in children age 6-11 years. J Allergy Clin Immunol 2005: 115: S105.
20. PITSIU M, HUSSEIN Z, MAJID O, AARONS L, DE LONGUEVILLE M, STOCKIS A. Retrospective population pharmacokinetic analysis of cetirizine in children aged 6 months to 12 years. Br J Clin Pharmacol 2004: 57: 402-11.
21. MENTRÉ F, DUBRUC C, THÉNOT J-P. Population pharmacokinetic analysis and optimization of the experimental design for mizolastine solution in children. J Pharmacokinet Pharmacodyn 2001: 28: 299-319.
22. FDA Guidance for Industry: Population Pharmacokinetics. February 1999.
23. WARNER JO, on behalf of the ETAC study group. A double-blind, randomized, placebo-controlled trial of cetirizine in preventing the onset of asthma in children with atopic dermatitis: 18 months' treatment and 18 months' post-treatment follow-up. J Allergy Clin Immunol 2001: 108: 929-37.
24. DIEPGEN TL, on behalf of the ETAC Study Group. Long-term treatment with cetirizine of infants with atopic dermatitis: a multi-country, double-blind, randomized, placebo-controlled trial (the ETAC trial) over 18 months. Pediatr Allergy Immunol 2002: 13: 278-86.
25. SIMONS FER, on behalf of the ETAC Study Group. Prevention of acute urticaria in young children with atopic dermatitis. J Allergy Clin Immunol 2001: 107: 703-6.
26. 1-receptor antagonist cetirizine in very young children with atopic dermatitis. J Allergy Clin Immunol 1999: 104: 433-40.
27. 1-receptor antagonist cetirizine on the behavioral, cognitive and psychomotor development of very young children with atopic dermatitis. Pediatr Res 2002: 52: 251-7.
28. de LONGUEVILLE M, DERUYTER B. RR, QT, and QTc in799 infants aged 1-2 years. J Allergy Clin Immunol 1998: 101: S198.
29. HUSSEIN Z, PITSIU M, MAJID O, AARONS L, DE LONGUEVILLE M, STOCKIS A. Retrospective population pharmacokinetics of levocetirizine in atopic children receiving cetirizine: the ETAC study. Br J Clin Pharmacol 2005: 59: 28-37.
30. CHOI SO, LEE SH, KONG HS, KIM EJ, CHOO HY. Stereoselective determination of cetirizine and studies on pharmacokinetics in rat plasma. J Chromatogr B Biomed Sci Appl 2000: 744: 201-6.
31. SHEINER L, BEAL S. NONMEM, Version 5.1, NONMEM Project Group. San Francisco: University of California, 1998.
32. TRAUB SL, JOHNSON CE. Comparison of methods of estimating creatinine clearance in children. Am J Hosp Pharm 1980: 37: 195-201.
33. REED MD, GAL P. Principles of drug therapy. In: BEHRMAN RE, KLIEGMAN RM, JENSON HB, eds. Nelson Textbook of Pediatrics, 17th edn. Philadelphia: Elsevier Science, 2004: 2427-32.
34. GIBALDI M, PERRIER D. Pharmacokinetics, 2nd edn. New York: Marcel Dekker, Inc., 1982: 16.
35. OKONKWO CA, COKER HAB, AGOMO PU, et al. Effect of chlorpheniramine on the pharmacokinetics of and response to chloroquine of Nigerian children with falciparum malaria. Trans R Soc Trop Med Hyg 1999: 93: 306-11.